Schedule 13G ownership disclosure

ZIOPHARM ONCOLOGY INC

Security class unavailable · CUSIP: 98973P101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
11,722,163
Percent of class
9.2700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019231-15-000014
Form type
SC 13G/A
Filer
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
CIK
CIK 1019231
Filed
May 15, 2015
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub